Dr. Weiner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
750 Washington St
# Ne
Boston, MA 02111Phone+1 617-636-5000Fax+1 617-636-6204
Summary
- Dr. Daniel Weiner is a nephrologist in Boston, MA. He received his medical degree from Tufts University School of Medicine and has been in practice 19 years. He is experienced in general nephrology and dialysis.
Education & Training
- Tufts Medical CenterFellowship, Nephrology, 2002 - 2005
- Sackler School of Biomedical Sciences, Tufts UniversityMSc, Clinical Research Graduate Program, 2002 - 2004
- University of MarylandResidency, Internal Medicine, 1998 - 2002
- Tufts University School of MedicineClass of 1998
- Tufts UniversityBA, Classics and Ancient History, 1990 - 1994
Certifications & Licensure
- MA State Medical License 2002 - 2026
- MD State Medical License 2001 - 2003
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 74 citationsCognitive Decline and Its Risk Factors in Prevalent Hemodialysis PatientsDavid A. Drew, Daniel E. Weiner, Hocine Tighiouart, Sarah Duncan, Aditi Gupta
American Journal of Kidney Diseases. 2017-06-01 - 339 citationsHyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.Richard J. Johnson, George L. Bakris, Claudio Borghi, Michel Chonchol, David L. Feldman
American Journal of Kidney Diseases. 2018-06-01 - 393 citationsNomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.Andrew S. Levey, Kai-Uwe Eckardt, Nijsje M. Dorman, Stacy L. Christiansen, Ewout J. Hoorn
Kidney International. 2020-06-01
Journal Articles
- Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD (SPin-D): A Randomized, Placebo-Controlled, Multiple Dosage TrialDavid M Charytan, Jonathan Himmelfarb, Adriana M Hung, Rajnish Mehrotra, Shailendra Sharma, Daniel E Weiner, Alan S Kliger, Laura M Dember, Kidney International
- Characterizing Approaches to Dialysis Decision Making with Older AdultsDaniel E Weiner, John B Wong, Ronald D Perrone, Klemens B Meyer, Journal of the American Society of Nephrology
- Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT TrialDaniel E Weiner, Meyeon Park, Alin A Joseph, Nitender Goyal, Chi-Yuan Hsu, Clifton E Kew, Todd E Pesavento, Andrew S Levey, American Journal of Kidney Diseases
- Join now to see all
Books/Book Chapters
Lectures
- Ultrafiltration Quality Metric Debate: Too Fast or Too Slow?American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019
- Nephrology Payment 2020, Including the Christopher R. Blagg, MD, Lectureship in Kidney Diseases and Public PolicyAmerican Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/8/2019
- How to Care for Dialysis Patients in a World of Population Quality MetricsPhiladelphia, PA - 1/1/2014
- Join now to see all
Authored Content
- Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant RecipientsAugust 2018
- Acute Kidney Injury in Sugarcane Workers at Risk for Mesoamerican NephropathyJuly 2018
- Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney FoundationFebruary 2018
- Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney FoundationFebruary 2018
- Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial CohortJune 2017
- Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial CohortJune 2017
- Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial CohortJune 2017
- Join now to see all
Press Mentions
- Do You Need to Monitor Your Blood Pressure at Home?March 25th, 2023
- Novel Agents Promising in Pruritus, Rare Metabolic Disease, and MoreApril 10th, 2022
- Daniel E. Weiner, MD, Receives Top Research Award from NKFApril 4th, 2022
- Join now to see all
Committees
- Member, KDOQI Hemodialysis Adequacy Clinical Practice Guidelines Update Work Group, National Kidney Foundation 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: